CRANBURY, N.J. – CRANBURY, N.J. (AP) _ Amicus Therapeutics Inc. (FOLD) on Tuesday reported a loss of $61.8 million in its second quarter.
The Cranbury, New Jersey-based company said it had a loss of 33 cents per share.
The results met Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was also for a loss of 33 cents per share.
The pharmaceutical company posted revenue of $21.3 million in the period, topping Street forecasts. Three analysts surveyed by Zacks expected $18.9 million.
Amicus Therapeutics shares have risen slightly more than 1 percent since the beginning of the year. The stock has climbed 10 percent in the last 12 months.
_____
This story was generated by Automated Insights using data from Zacks Investment Research. Access a Zacks stock report on FOLD at https://www.zacks.com/ap/FOLD
The hottest stories ripped from the headlines, from crime to courts, legal and scandal.
